Skip to content

Reproducibility Study of Over Active Bladder Symptom Score [OABSS]

Reproducibility Study of OABSS and Its Response to Treatment - Part 1: Reproducibility -

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00901251
Acronym
RESORT
Enrollment
50
Registered
2009-05-13
Start date
2009-01-31
Completion date
2009-05-31
Last updated
2011-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder

Keywords

OABSS

Brief summary

The purpose of this study is to evaluate the reproducibility of over active bladder symptom score (OABSS) in Asian countries.

Interventions

None listed

Sponsors

Astellas Pharma China, Inc.
CollaboratorINDUSTRY
Astellas Pharma Inc
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Symptoms OAB for 3 months or longer * At least 1 urgency episode in last 3 days * Symptoms of OAB as verified by the screening 3-day bladder diary, defined by: * Number of micturition ≥8 times/day * Number of urgency episode in 3 days ≥1

Exclusion criteria

* Indwelling catheters or practicing intermittent self-catheterization * Symptomatic urinary tract infection, chronic inflammation * Diabetic neuropathy

Design outcomes

Primary

MeasureTime frame
OABSSWeeks of 0 and 2

Secondary

MeasureTime frame
3-day micturition diary2 times in 2-week interval

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026